Followers | 6 |
Posts | 507 |
Boards Moderated | 0 |
Alias Born | 02/29/2008 |
Wednesday, June 08, 2016 3:26:05 PM
AnGes has signed an agreement with Vical Inco
rporated (San Diego, CA
, President & CEO:
Vijay B. Samant) regarding Vical’s DNA va
ccine technology. This agreement gives AnGes
the rights to exclusively develop and commercia
lize the equine polyclonal antibody therapy in
Japan.
http://s1.q4cdn.com/508380786/files/doc_downloads/AnGes-Ebola-PR/AnGes-U.-of-Saskatchewan-Ebola-Collaboration.pdf
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM